Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.01 | $0.05 | $0.01 |
| Q2 2026 | 3 | $0.02 | $0.03 | $0.02 |
| Q3 2026 | 3 | $0.00 | $0.00 | $0.00 |
| Q4 2026 | 1 | $0.01 | $0.01 | $0.01 |
| Q1 2027 | 1 | -$0.00 | -$0.00 | -$0.00 |
| Q2 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q3 2027 | 1 | $0.00 | $0.00 | $0.00 |
| Q4 2027 | 1 | $0.01 | $0.01 | $0.01 |
Health Catalyst Inc last posted its earnings results on Monday, May 11th, 2026. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.01. The company had revenue of 70.76 M for the quarter and had revenue of 311.14 M for the year. Health Catalyst Inc has generated $-3 earnings per share over the last year ($-2.55 diluted earnings per share) and currently has a price-to-earnings ratio of -0.37. Health Catalyst Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/11/2026 | Q1 2026 | $0.01 | -$1.53 | -1.54 | $69.24 M | $70.76 M |
| 03/12/2026 | Q4 2025 | $0.09 | -$1.28 | -1.37 | $73.97 M | $74.68 M |
| 11/10/2025 | Q3 2025 | $0.05 | -$0.32 | -0.37 | $75.01 M | $76.32 M |
| 08/08/2025 | Q2 2025 | N/A | -$0.59 | N/A | $80.62 M | $80.72 M |
| 05/09/2025 | Q1 2025 | N/A | -$0.35 | N/A | $79.18 M | $79.41 M |
| 02/26/2025 | Q4 2024 | $0.11 | -$0.33 | -0.44 | $79.65 M | $79.61 M |
| 11/06/2024 | Q3 2024 | N/A | -$0.24 | N/A | $76.27 M | $76.35 M |
| 08/07/2024 | Q2 2024 | N/A | -$0.23 | N/A | $74.96 M | $75.90 M |
| 05/09/2024 | Q1 2024 | N/A | -$0.35 | N/A | $74.82 M | $74.72 M |
| 02/22/2024 | Q4 2023 | $0.00 | -$0.53 | -0.53 | N/A | $75.08 M |
| 11/06/2023 | Q3 2023 | N/A | -$0.39 | N/A | N/A | $73.77 M |
| 08/08/2023 | Q2 2023 | N/A | -$0.58 | N/A | N/A | $73.21 M |
| 05/09/2023 | Q1 2023 | N/A | -$0.60 | N/A | N/A | $73.87 M |
| 02/28/2023 | Q4 2022 | -$0.10 | -$0.66 | -0.56 | N/A | $69.16 M |
| 11/08/2022 | Q3 2022 | N/A | -$0.84 | N/A | N/A | $68.35 M |
| 08/04/2022 | Q2 2022 | N/A | -$0.62 | N/A | N/A | $70.63 M |
| 05/10/2022 | Q1 2022 | -$0.08 | -$0.42 | -0.34 | N/A | $68.09 M |
| 03/01/2022 | Q4 2021 | -$0.21 | -$0.94 | -0.73 | N/A | $64.72 M |
| 11/09/2021 | Q3 2021 | -$0.22 | -$0.82 | -0.6 | N/A | $61.74 M |
| 08/05/2021 | Q2 2021 | N/A | -$0.80 | N/A | N/A | $59.63 M |
In the previous quarter, Health Catalyst Inc (:HCAT) reported $0.02 earnings per share (EPS) to beat the analysts' consensus estimate of $0.01 by $0.01.
The conference call for Health Catalyst Inc's latest earnings report can be listened to online.
The conference call transcript for Health Catalyst Inc's latest earnings report can be read online.
Health Catalyst Inc (:HCAT) has a recorded annual revenue of $311.14 M.
Health Catalyst Inc (:HCAT) has a recorded net income of $-177,974,000.Health Catalyst Inc has generated $-2.55 earnings per share over the last four quarters.
Health Catalyst Inc (:HCAT) has a price-to-earnings ratio of -0.37 and price/earnings-to-growth ratio is 0.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED